IHC image of CSB-PA707717LA01HU diluted at 1:400 and staining in paraffin-embedded human liver cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
IHC image of CSB-PA707717LA01HU diluted at 1:400 and staining in paraffin-embedded human liver cancer performed on a Leica BondTM system. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.
SPINK9 Antibody
CSB-PA707717LA01HU
ApplicationsELISA, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman
TargetSPINK9
Overview
- SupplierCusabio
- Product NameSPINK9 Antibody
- Delivery Days Customer20
- ApplicationsELISA, ImmunoHistoChemistry
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- FormulationLiquid
- Gene ID643394
- Target nameSPINK9
- Target descriptionserine peptidase inhibitor Kazal type 9
- Target synonymsLEKTI2; lymphoepithelial Kazal-type-related inhibitor 2; serine protease inhibitor Kazal-type 9
- HostRabbit
- IsotypeIgG
- Protein IDQ5DT21
- Protein NameSerine protease inhibitor Kazal-type 9
- Scientific DescriptionSerine protease inhibitor which specifically inhibits KLK5. May contribute to the regulation of the desquamation process in skin by inhibiting KLK5.
- ReactivityHuman
- Storage Instruction-20°C or -80°C
- UNSPSC12352203